A Nordic Phase II Study on Dose-Intensive Induction and High-Dose Therapy (HDT) with Autologous Stem Cell Rescue (ASCR) as primary Treatment for Peripheral T-cell lymphomas (

Autor: d'Amore, Francesco Annibale, Holte, Harald, Cavallin-Ståhl, E, Jantunen, Esa, Hagberg, Hans, Ralfkiaer, Elisabeth, Anderson, Harald, Lauritzsen, Grete, Osterborg, Anders, Merup, Mats, Hansen, M, Telhaug, Ragnar, Delabie, Jan, Sundstrom, Christer

Publikováno v: d'Amore, F A, Holte, H, Cavallin-Ståhl, E, Jantunen, E, Hagberg, H, Ralfkiaer, E, Anderson, H, Lauritzsen, G, Osterborg, A, Merup, M, Hansen, M, Telhaug, R, Delabie, J & Sundstrom, C 2009, ' A Nordic Phase II Study on Dose-Intensive Induction and High-Dose Therapy (HDT) with Autologous Stem Cell Rescue (ASCR) as primary Treatment for Peripheral T-cell lymphomas ( ', A Nordic Phase II Study on Dose-Intensive Induction and High-Dose Therapy (HDT) with Autologous Stem Cell Rescue (ASCR) as primary Treatment for Peripheral T-cell lymphomas (, 17/12/2010 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::db0b8b44c9a424a46c81fdaed528ec3c
https://pure.au.dk/portal/da/publications/a-nordic-phase-ii-study-on-doseintensive-induction-and-highdose-therapy-hdt-with-autologous-stem-cell-rescue-ascr-as-primary-treatment-for-peripheral-tcell-lymphomas-(195c1a30-0335-11de-a987-000ea68e967b).html

Dose-dense induction followed by autolous stern cell transplant (ASCT) as 1st line treatment in peripheral T-cell lymphomas (PTCL) -:A phase II study of the Nordic Lymphoma Group

Autor: D'Amore, Francesco, Relander, Thomas, Lauritzsen, Grethe, Jantunen, Esa, Hagberg, Hans, Anderson, Harald, Cavallin-Ståhl, Eva, Holte, Harald, Østerborg, Anders, Merup, Mats, Hansen, Mads, Telhaug, Ragnar, Erlandson, Martin, Kuittinen, Outi, Gadeberg, Ole Vestergaard, Delabie, Jan, Sundström, Christer, Ralfkiær, Elisabeth, Vornanen, Marine, Jensen, Charlotte B.

Publikováno v: D'Amore, F, Relander, T, Lauritzsen, G, Jantunen, E, Hagberg, H, Anderson, H, Cavallin-Ståhl, E, Holte, H, Østerborg, A, Merup, M, Hansen, M, Telhaug, R, Erlandson, M, Kuittinen, O, Gadeberg, O V, Delabie, J, Sundström, C, Ralfkiær, E, Vornanen, M & Jensen, C B 2006 ' Dose-dense induction followed by autolous stern cell transplant (ASCT) as 1st line treatment in peripheral T-cell lymphomas (PTCL)-: A phase II study of the Nordic Lymphoma Group. ' .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::7220e29da8842cc8e95ffbe8a7f1cc77
https://portal.findresearcher.sdu.dk/da/publications/46f009c0-d6e6-11db-bc51-000ea68e967b

Chlvpp is as Effective as Alternating ChlvppAbod in Advanced Stage Hodgkin's Disease.

Autor: Holte, Harald, Mella, Olav, Wist, Ertk, Telhaug, Ragnar, Hannisdal, Einar, Abrahamsen, Arne Foss

Publikováno v: Acta Oncologica; 1996, Vol. 35 Issue S8, p73-80, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[High-dose treatment with autologous stem cell support in a Norwegian region].

Autor: Hammerstrøm J; St. Olavs Hospital, 7600 Trondheim. jens.hammerstrom@medisin.ntnu.no, Aasland IL, Telhaug R, Moen T, Lødemel B, Sørum Y, Brudevold R, Herlofsen O, Sørbø JH, Almvik T, Lamvik J

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2004 Oct 07; Vol. 124 (19), pp. 2498-500.